Michael L. Blum - Jan 1, 2023 Form 4 Insider Report for Homology Medicines, Inc. (FIXX)

Role
Chief Commercial Officer
Signature
/s/ W. Bradford Smith, Attorney-in-Fact for Michael L. Blum
Stock symbol
FIXX
Transactions as of
Jan 1, 2023
Transactions value $
$0
Form type
4
Date filed
1/4/2023, 03:37 PM
Previous filing
Jan 20, 2023
Next filing
Jan 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FIXX Common Stock Options Exercise +2.64K +31.42% 11K Jan 1, 2023 Direct F1, F2
transaction FIXX Common Stock Options Exercise +4.95K +44.83% 16K Jan 1, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FIXX Restricted Stock Units Options Exercise $0 -2.64K -49.25% $0.00 2.72K Jan 1, 2023 Common Stock 2.64K Direct F1, F3
transaction FIXX Restricted Stock Units Options Exercise $0 -4.95K -33% $0.00 10.1K Jan 1, 2023 Common Stock 4.95K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
F2 Includes 630 shares acquired under Issuer's Employee Stock Purchase Plan on February 28, 2022 and 992 shares acquired under Issuer's Employee Stock Purchase Plan on August 31, 2022.
F3 The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one half of the RSUs on each of January 1, 2023 and January 1, 2024. The RSUs do not have an expiration date.
F4 The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025. The RSUs do not have an expiration date.

Remarks:

Exhibit 24 - Power of Attorney